Beam Therapeutics, Inc. (BEAM)
27.43
+1.10
(+4.18%)
USD |
NASDAQ |
Apr 10, 16:00
27.59
+0.16
(+0.58%)
After-Hours: 20:00
Beam Therapeutics Free Cash Flow : -360.05M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Twist Bioscience Corp. | -86.72M |
| Intellia Therapeutics, Inc. | -395.86M |
| Stryker Corp. | 4.283B |
| Zimmer Biomet Holdings, Inc. | 1.120B |
| Tandem Diabetes Care, Inc. | -29.67M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -83.29M |
| Cash from Investing (Quarterly) | 108.41M |
| Cash from Financing (Quarterly) | 1.886M |
| Free Cash Flow Per Share (Quarterly) | -0.8294 |
| Free Cash Flow to Equity (Quarterly) | -89.73M |
| Free Cash Flow to Firm (Quarterly) | -87.02M |
| Free Cash Flow Yield | -13.21% |